BENCHMARK PROFILE
Next Chems
Latest sync: Sep 8, 2026, 8:55 AM. Source coverage currently reflects PB Evidence data.
REFERRAL OFFER
10% off with disclosed code
Checkout-verified 2026-07-20: the PeptideBenchmark code applies 10% to regular-price merchandise at one and five units. Sale-only carts reject it as inapplicable, so current SKU sales remain a separate non-stacking lane.
PeptideBenchmark has a disclosed affiliate relationship with Next Chems. This does not change benchmark scores or trust ratings — it only affects outbound links and pricing-board discount modeling where applicable.
Readers who want the vendor represented with real structured pricing plus at least a confirmed public documentation trail, even if that trust trail is still relatively thin.
The pricing surface is stronger than the current public trust surface. Readers should treat Next Chems as a vendor with partial public documentation, not as a leader in catalog-wide verification transparency.
Included because it now has real structured coverage: a public product sitemap, live product-page pricing, and a small but genuine public lab-results surface.
A mixed but still legitimate public case. Next Chems exposes a browsable public storefront with product-level pricing and inline dosage variants, while the trust side currently rests on a narrow public COA page plus repeated product-page “COA available” language rather than a broad certificate archive.
Next Chems currently exposes a small public lab-results / COAs page with vendor-hosted PDFs, and many product pages also make an explicit public COA-available claim. That is enough to create a real trust profile, but it is still much narrower than the broad archive or provider-run verification patterns we treat as stronger proof tiers.
This vendor is one of 113 names currently included in our manual curated research-vendor layer.
This is a meaningful public transparency pattern, but the documents are still mostly hosted on the vendor side. That makes it stronger than generic claims and weaker than provider-controlled verification.
- Reward the fact that readers can inspect real files without logging in.
- Pay attention to whether the archive is broad, multi-category, or repeated across many products.
- Keep in mind that vendor-hosted files are different from a live third-party verification portal.
This vendor makes the most sense when you compare it to other vendors using a similar transparency model, rather than to every vendor on the board at once.
PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.
Next Chems has enough public trust structure to be useful in the curated set, even if it is not one of the clearest verification leaders yet.
Readers can inspect real public documents, even if the vendor still hosts most of the archive.
The trust layer is structured and inspectable, but still mostly vendor-controlled.
Current review touched 47 products and 6 document/link destinations.
0 named lab signal(s) and 1 certification category signal(s) are currently visible in the reviewed evidence.
Score 2.0 from pb evidence score.
PB Curated Assessment: Promising. This is our own trust/transparency rubric and is kept separate from the PB score.
Observed from public domain records and the vendor's own site on Aug 27, 2026. Identity facts are shown for context and do not affect scores. We could not read some of this vendor’s pages, so “Unknown” means we could not look — not that nothing is published.
Holding a certificate for this vendor that is not here?Send it to the archive →
Same third-party review signals shown on the vendor board. Click Trustpilot or Pep Review Pro to open the source profile.
PB score is the number you should read first on this page. It starts with trust evidence, pricing coverage, and third-party review signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available. Reviewed transparency evidence contributes a bounded amount — shown as a trust lift for source-benchmarked vendors, and folded into the base score for PB-evidence vendors.
This vendor’s score is evidence-first: verifiable testing evidence forms the backbone, and outside review sources are a bounded adjustment that can warn far more than it can boost. The terms below sum to the displayed score (small rounding aside). Full formula on the scoring methodology page.
WHAT THIS PAGE IS
- Board-ranked vendor profile with source-linked benchmark inputs
- No Finnrick score currently linked
- No Peptide Critic score currently linked
- No Trustpilot profile currently linked
- No Pep Review Pro profile currently linked
CURRENT LIMITS
- Not an original lab test or editorial review
- Source scales and methodologies differ across sites
- Depends on source site freshness and formatting
These are representative public examples from the vendor testing review queue. They show how product pages in the catalog expose public report or verification paths, but they should still be read as examples rather than proof for every current lot.
In other words: the relationship registry above captures the vendor-to-provider link itself, while the examples below show what that link looks like across real product pages.
METHODOLOGY
How to read this benchmark
This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.
A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.
Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.